6 months progress after minoxidil/finasteride stopped working
    Progress Pictures 10/20/2024

    From the encyclopedia
    Finasteride →

    Frontline, gold standard treatment for combatting androgenic alopecia

    Minoxidil →

    An essential vasodilator with some anti-androgenic effects

    Redensyl →

    commercial product with a blend of mostly natural ingredients for hair regrowth

    At a glance
    In this treatment experience post, the primary subjects mentioned are
    💊 Finasteride (oral) 6 months
    💧 Minoxidil (topical) 3 years
    💧 Finasteride (topical) 0.1% nightly 1.5 years
    💧 Minoxidil (topical) 5% nightly 1.5 years
    💧 Redensyl (topical) nightly
    Microneedling (dermapen) 1.5mm every 3 weeks 1.5 years
    💧 Anti-dandruff shampoo (topical) 2x weekly
    💧 Everyday shampoo (topical) 5x weekly
    💧 Scalp brushing (topical) weekly
    the tone is 😀 positive with new hair growth results.

    Other terms

    A 24-year-old with male pattern baldness experienced side effects from oral finasteride and switched to a topical minoxidil/finasteride combination, later incorporating daily shampooing and scalp brushing to manage hair loss and dandruff. After initial shedding, the regimen led to reduced hair loss and new hair growth, with the user now using a densita mf combination (5% minoxidil/0.1% finasteride + redensyl) nightly.
    View this post in the Community →

    Similar Community Posts Join

    5 / 5 results

    Related Research

    6 / 6 results
      Minoxidil: A Comprehensive Review

      research Minoxidil: a comprehensive review

      16 citations , June 2021 in “Journal of Dermatological Treatment”
      This study reported that while topical minoxidil exhibits hair regrowth in androgenetic alopecia, oral minoxidil 5 mg/day was more effective than topical forms after six months, with low doses also potentially effective for women and other hair loss types.
      Proceedings of the Ninth World Congress for Hair Research 2015

      research Proceedings of the Ninth World Congress for Hair Research (2015)

      January 2017 in “Journal of Investigative Dermatology Symposium Proceedings”
      This report discusses the Ninth World Congress for Hair Research and highlights the potential of hair follicle studies to advance understanding of various diseases, with no new clinical results presented.
      The Rise of Transcutaneous Drug Delivery for the Management of Alopecia: A Review of Existing Literature and an Eye Towards the Future

      research The rise of transcutaneous drug delivery for the management of alopecia: a review of existing literature and an eye towards the future

      9 citations , October 2018 in “Journal of Cosmetic and Laser Therapy”
      This study reviewed eight studies investigating transcutaneous drug delivery via fractional laser and microneedling for alopecia treatment, with six studies showing improved hair regrowth over topical therapy alone, suggesting its potential as a promising treatment strategy, although further research is needed to refine treatment parameters.
      An Overview of Female Pattern Hair Loss

      research An overview of female pattern hair loss

      2 citations , June 2011 in “Expert Review of Dermatology”
      This review discusses the characteristics and management options for female pattern hair loss, highlighting the unclear role of androgens and the psychosocial impact, and reports no new clinical results.
      Comparison of Metabolic Syndrome Parameters, Trichoscopic and Trichoscan Characteristics in Androgenetic Alopecia and Early-Onset Androgenetic Alopecia

      research The Comparison of Metabolic Syndrome Parameters, Trichoscopic and Trichoscan Characteristics in Androgenetic Alopecia (AGA) and Early-Onset Androgenetic Alopecia (Early-Onset AGA)

      June 2024 in “Research Square (Research Square)”
      In this cross-sectional study, researchers observed that individuals with early-onset androgenetic alopecia showed significant differences in hair growth parameters and metabolic factors compared to those with normal-onset AGA, suggesting a potential association with metabolic syndrome, though more research is needed to clarify this relationship.
      Telogen Effluvium: Comprehensive Overview and Treatment

      research Telogen Effluvium

      3 citations , February 2008 in “Basic and clinical dermatology”
      Telogen Effluvium is a hair loss condition where treatment involves identifying and managing its triggers.